Skip to main content
Fig. 1 | Biomarker Research

Fig. 1

From: High expression of TMEM244 is associated with poor overall survival of patients with T-cell lymphoma

Fig. 1

The expression level of TMEM244 in TCL and T-ALL, and its prognostic value in TCL patients. A TMEM244 expression levels in healthy individuals (HIs) and patients with TCL or T-ALL in the JNU (left panel), GSE132550 (middle panel), and GSE113113 (right panel) datasets. B Percentage in T-ALL patients with no or trace expression of TMEM244 in the JNU-T-ALL (left panel) and PRJCA002270 (right panel) datasets. C The sensitivity and accuracy of high TMEM244 expression in diagnosing TCL compared with T-ALL. D Clinical utility curve for diagnosing TCL and T-ALL in the JNU dataset. E The overall survival (OS) for the low and high TMEM244 expression subgroups in the total TCL patients (left panel) and patients treated with chemotherapy (right panel) in the JNU-TCL dataset. AUC: Area under the curve; CI: Confidence interval; CTCL: Cutaneous T-cell lymphoma; HR: Hazard ratio; PTCL: Peripheral T-cell lymphoma; ROC: Receiver operating characteristic

Back to article page